Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for FOXK1_FOXP2_FOXB1_FOXP3
Z-value: 3.39
Motif logo
Transcription factors associated with FOXK1_FOXP2_FOXB1_FOXP3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
FOXK1
|
ENSG00000164916.9 | forkhead box K1 |
|
FOXP2
|
ENSG00000128573.18 | forkhead box P2 |
|
FOXB1
|
ENSG00000171956.5 | forkhead box B1 |
|
FOXP3
|
ENSG00000049768.10 | forkhead box P3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FOXP3 | hg19_v2_chrX_-_49121165_49121288 | -0.78 | 1.3e-07 | Click! |
| FOXP2 | hg19_v2_chr7_+_114055052_114055378 | 0.58 | 4.5e-04 | Click! |
| FOXK1 | hg19_v2_chr7_+_4721885_4721945 | -0.41 | 2.1e-02 | Click! |
| FOXB1 | hg19_v2_chr15_+_60296421_60296464 | -0.19 | 3.1e-01 | Click! |
Activity profile of FOXK1_FOXP2_FOXB1_FOXP3 motif
Sorted Z-values of FOXK1_FOXP2_FOXB1_FOXP3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_-_71551652 | 19.93 |
ENST00000546561.1
|
TSPAN8
|
tetraspanin 8 |
| chr17_+_72426891 | 14.04 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr12_-_71551868 | 12.39 |
ENST00000247829.3
|
TSPAN8
|
tetraspanin 8 |
| chr4_-_152149033 | 12.11 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
| chr10_+_123923105 | 11.91 |
ENST00000368999.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr10_-_101841588 | 11.70 |
ENST00000370418.3
|
CPN1
|
carboxypeptidase N, polypeptide 1 |
| chr10_+_123923205 | 10.69 |
ENST00000369004.3
ENST00000260733.3 |
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr17_+_9745786 | 10.17 |
ENST00000304773.5
|
GLP2R
|
glucagon-like peptide 2 receptor |
| chr10_+_123922941 | 10.16 |
ENST00000360561.3
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr5_-_42811986 | 10.09 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
| chr5_-_42812143 | 9.91 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
| chr11_+_124789146 | 9.15 |
ENST00000408930.5
|
HEPN1
|
hepatocellular carcinoma, down-regulated 1 |
| chr4_-_186456652 | 9.11 |
ENST00000284767.5
ENST00000284770.5 |
PDLIM3
|
PDZ and LIM domain 3 |
| chr17_-_64225508 | 9.07 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr1_-_57431679 | 9.02 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
| chr5_-_36301984 | 8.94 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
| chr3_+_148447887 | 8.91 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
| chr10_-_52645416 | 8.38 |
ENST00000374001.2
ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF
|
APOBEC1 complementation factor |
| chr17_+_72427477 | 8.35 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr1_+_171154347 | 8.30 |
ENST00000209929.7
ENST00000441535.1 |
FMO2
|
flavin containing monooxygenase 2 (non-functional) |
| chr7_+_134551583 | 8.18 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
| chr11_+_27076764 | 8.13 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr12_-_91574142 | 8.11 |
ENST00000547937.1
|
DCN
|
decorin |
| chr12_+_13349711 | 7.99 |
ENST00000538364.1
ENST00000396301.3 |
EMP1
|
epithelial membrane protein 1 |
| chr20_-_22559211 | 7.85 |
ENST00000564492.1
|
LINC00261
|
long intergenic non-protein coding RNA 261 |
| chr14_-_21493649 | 7.48 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
| chr3_+_159570722 | 7.47 |
ENST00000482804.1
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr12_-_9268707 | 7.41 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
| chr8_+_120079478 | 7.34 |
ENST00000332843.2
|
COLEC10
|
collectin sub-family member 10 (C-type lectin) |
| chr12_+_13349650 | 7.33 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
| chr20_-_7921090 | 7.27 |
ENST00000378789.3
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1 |
| chr9_+_27109440 | 7.17 |
ENST00000519080.1
|
TEK
|
TEK tyrosine kinase, endothelial |
| chr11_-_111781610 | 7.13 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
| chr4_-_186456766 | 6.90 |
ENST00000284771.6
|
PDLIM3
|
PDZ and LIM domain 3 |
| chr11_-_111781554 | 6.90 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
| chr3_+_158787041 | 6.82 |
ENST00000471575.1
ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chr10_-_45474237 | 6.76 |
ENST00000448778.1
ENST00000298295.3 |
C10orf10
|
chromosome 10 open reading frame 10 |
| chr21_-_40033618 | 6.74 |
ENST00000417133.2
ENST00000398910.1 ENST00000442448.1 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
| chr9_+_27109392 | 6.72 |
ENST00000406359.4
|
TEK
|
TEK tyrosine kinase, endothelial |
| chr10_-_13570533 | 6.68 |
ENST00000396900.2
ENST00000396898.2 |
BEND7
|
BEN domain containing 7 |
| chr10_+_24755416 | 6.55 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr12_-_53343602 | 6.51 |
ENST00000546897.1
ENST00000552551.1 |
KRT8
|
keratin 8 |
| chr1_+_200011711 | 6.35 |
ENST00000544748.1
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr4_+_111397216 | 6.26 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
| chr1_+_162602244 | 6.11 |
ENST00000367922.3
ENST00000367921.3 |
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
| chr7_+_114055052 | 6.09 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
| chr18_+_29171689 | 6.07 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr3_-_148939598 | 6.01 |
ENST00000455472.3
|
CP
|
ceruloplasmin (ferroxidase) |
| chr8_+_77593474 | 5.96 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
| chr4_+_15376165 | 5.92 |
ENST00000382383.3
ENST00000429690.1 |
C1QTNF7
|
C1q and tumor necrosis factor related protein 7 |
| chr6_-_56707943 | 5.89 |
ENST00000370769.4
ENST00000421834.2 ENST00000312431.6 ENST00000361203.3 ENST00000523817.1 |
DST
|
dystonin |
| chr3_-_164914640 | 5.86 |
ENST00000241274.3
|
SLITRK3
|
SLIT and NTRK-like family, member 3 |
| chr2_-_165424973 | 5.83 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr4_-_88450244 | 5.76 |
ENST00000503414.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr11_-_111781454 | 5.71 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
| chr15_+_69857515 | 5.71 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
| chr16_-_86542652 | 5.69 |
ENST00000599749.1
|
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
| chr5_-_16742330 | 5.66 |
ENST00000505695.1
ENST00000427430.2 |
MYO10
|
myosin X |
| chr17_-_64216748 | 5.62 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr12_-_53343633 | 5.41 |
ENST00000546826.1
|
KRT8
|
keratin 8 |
| chr10_+_75668916 | 5.40 |
ENST00000481390.1
|
PLAU
|
plasminogen activator, urokinase |
| chr2_+_201450591 | 5.39 |
ENST00000374700.2
|
AOX1
|
aldehyde oxidase 1 |
| chr2_-_69098566 | 5.38 |
ENST00000295379.1
|
BMP10
|
bone morphogenetic protein 10 |
| chrX_-_10851762 | 5.37 |
ENST00000380785.1
ENST00000380787.1 |
MID1
|
midline 1 (Opitz/BBB syndrome) |
| chr9_-_104198042 | 5.35 |
ENST00000374855.4
|
ALDOB
|
aldolase B, fructose-bisphosphate |
| chrX_+_105936982 | 5.34 |
ENST00000418562.1
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr5_-_115872142 | 5.34 |
ENST00000510263.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
| chr9_+_27109133 | 5.32 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
| chr1_+_13910194 | 5.31 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
| chr10_-_52645379 | 5.27 |
ENST00000395489.2
|
A1CF
|
APOBEC1 complementation factor |
| chr12_-_53343560 | 5.27 |
ENST00000548998.1
|
KRT8
|
keratin 8 |
| chr10_-_69597915 | 5.26 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr4_-_100212132 | 5.25 |
ENST00000209668.2
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide |
| chr18_+_56113488 | 5.24 |
ENST00000590797.1
|
RP11-1151B14.3
|
RP11-1151B14.3 |
| chr1_-_26394114 | 5.22 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
| chr6_+_53883708 | 5.19 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
| chr12_-_21928515 | 5.14 |
ENST00000537950.1
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
| chr17_-_10450866 | 5.14 |
ENST00000578017.1
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr3_-_185826855 | 5.13 |
ENST00000306376.5
|
ETV5
|
ets variant 5 |
| chr5_+_149980622 | 5.12 |
ENST00000394243.1
|
SYNPO
|
synaptopodin |
| chr4_-_186733363 | 5.05 |
ENST00000393523.2
ENST00000393528.3 ENST00000449407.2 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr4_-_70361615 | 5.05 |
ENST00000305107.6
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr2_+_102953608 | 5.04 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr4_-_72649763 | 5.01 |
ENST00000513476.1
|
GC
|
group-specific component (vitamin D binding protein) |
| chr7_-_14028488 | 5.00 |
ENST00000405358.4
|
ETV1
|
ets variant 1 |
| chr12_-_9268819 | 4.94 |
ENST00000404455.2
|
A2M
|
alpha-2-macroglobulin |
| chr19_+_7580103 | 4.81 |
ENST00000596712.1
|
ZNF358
|
zinc finger protein 358 |
| chr1_-_60392452 | 4.80 |
ENST00000371204.3
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2 |
| chr2_+_74120094 | 4.79 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
| chr12_+_100867694 | 4.75 |
ENST00000392986.3
ENST00000549996.1 |
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr5_-_13944652 | 4.74 |
ENST00000265104.4
|
DNAH5
|
dynein, axonemal, heavy chain 5 |
| chr8_+_77593448 | 4.73 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
| chr4_-_110723134 | 4.66 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
| chr7_-_140340576 | 4.60 |
ENST00000275884.6
ENST00000475837.1 |
DENND2A
|
DENN/MADD domain containing 2A |
| chr2_-_188419078 | 4.50 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
| chr1_-_27240455 | 4.48 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
| chr4_-_88450535 | 4.46 |
ENST00000541496.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr10_-_69597828 | 4.45 |
ENST00000339758.7
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr4_-_70361579 | 4.43 |
ENST00000512583.1
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr11_-_18258342 | 4.40 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
| chr5_-_147211226 | 4.39 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr1_+_207277632 | 4.39 |
ENST00000421786.1
|
C4BPA
|
complement component 4 binding protein, alpha |
| chr14_-_74551172 | 4.37 |
ENST00000553458.1
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
| chr1_-_144995074 | 4.34 |
ENST00000534536.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr3_+_147127142 | 4.33 |
ENST00000282928.4
|
ZIC1
|
Zic family member 1 |
| chr14_-_74551096 | 4.26 |
ENST00000350259.4
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
| chr11_+_101983176 | 4.26 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
| chr5_-_142065612 | 4.26 |
ENST00000360966.5
ENST00000411960.1 |
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr7_+_134464414 | 4.22 |
ENST00000361901.2
|
CALD1
|
caldesmon 1 |
| chr14_-_94789663 | 4.22 |
ENST00000557225.1
ENST00000341584.3 |
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
| chr1_-_9563433 | 4.19 |
ENST00000441033.1
|
RP13-392I16.1
|
RP13-392I16.1 |
| chr12_-_22063787 | 4.17 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
| chr6_-_46922659 | 4.16 |
ENST00000265417.7
|
GPR116
|
G protein-coupled receptor 116 |
| chr4_-_88450372 | 4.08 |
ENST00000543631.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr10_+_7745303 | 4.04 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr2_-_188419200 | 4.04 |
ENST00000233156.3
ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
| chr6_-_127780510 | 4.01 |
ENST00000487331.2
ENST00000483725.3 |
KIAA0408
|
KIAA0408 |
| chr12_+_100867486 | 3.99 |
ENST00000548884.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr5_-_38557561 | 3.99 |
ENST00000511561.1
|
LIFR
|
leukemia inhibitory factor receptor alpha |
| chr12_+_53491220 | 3.96 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr12_-_71031185 | 3.95 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
| chr8_+_39972170 | 3.94 |
ENST00000521257.1
|
RP11-359E19.2
|
RP11-359E19.2 |
| chr4_-_186732048 | 3.94 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr3_+_108855558 | 3.94 |
ENST00000467240.1
ENST00000477643.1 ENST00000479039.1 ENST00000593799.1 |
RP11-59E19.1
|
RP11-59E19.1 |
| chr6_-_56716686 | 3.92 |
ENST00000520645.1
|
DST
|
dystonin |
| chr14_-_21493884 | 3.90 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
| chr14_+_32798462 | 3.86 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr21_-_35899113 | 3.86 |
ENST00000492600.1
ENST00000481448.1 ENST00000381132.2 |
RCAN1
|
regulator of calcineurin 1 |
| chr1_+_196912902 | 3.84 |
ENST00000476712.2
ENST00000367415.5 |
CFHR2
|
complement factor H-related 2 |
| chr3_+_174577070 | 3.84 |
ENST00000454872.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
| chr10_+_95848824 | 3.83 |
ENST00000371385.3
ENST00000371375.1 |
PLCE1
|
phospholipase C, epsilon 1 |
| chr17_+_68071389 | 3.81 |
ENST00000283936.1
ENST00000392671.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr7_+_134576317 | 3.78 |
ENST00000424922.1
ENST00000495522.1 |
CALD1
|
caldesmon 1 |
| chr2_+_173724771 | 3.78 |
ENST00000538974.1
ENST00000540783.1 |
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
| chr2_-_71454185 | 3.78 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
| chr4_-_88450511 | 3.77 |
ENST00000458304.2
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr6_+_8652370 | 3.74 |
ENST00000503668.1
|
HULC
|
hepatocellular carcinoma up-regulated long non-coding RNA |
| chr15_+_54305101 | 3.70 |
ENST00000260323.11
ENST00000545554.1 ENST00000537900.1 |
UNC13C
|
unc-13 homolog C (C. elegans) |
| chr19_+_41497178 | 3.68 |
ENST00000324071.4
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
| chr3_-_46608010 | 3.68 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
| chr6_+_53883790 | 3.67 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr11_-_72504681 | 3.67 |
ENST00000538536.1
ENST00000543304.1 ENST00000540587.1 ENST00000334805.6 |
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
| chr18_+_28898052 | 3.66 |
ENST00000257192.4
|
DSG1
|
desmoglein 1 |
| chr3_+_186330712 | 3.66 |
ENST00000411641.2
ENST00000273784.5 |
AHSG
|
alpha-2-HS-glycoprotein |
| chr4_-_88449771 | 3.65 |
ENST00000535835.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
| chr1_-_94079648 | 3.62 |
ENST00000370247.3
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
| chr5_-_95550754 | 3.61 |
ENST00000502437.1
|
RP11-254I22.3
|
RP11-254I22.3 |
| chrX_+_105937068 | 3.61 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr21_+_17792672 | 3.61 |
ENST00000602620.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr7_+_134464376 | 3.61 |
ENST00000454108.1
ENST00000361675.2 |
CALD1
|
caldesmon 1 |
| chr6_-_88875654 | 3.58 |
ENST00000535130.1
|
CNR1
|
cannabinoid receptor 1 (brain) |
| chr1_-_85870177 | 3.58 |
ENST00000542148.1
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr4_-_87279641 | 3.57 |
ENST00000512689.1
|
MAPK10
|
mitogen-activated protein kinase 10 |
| chr8_-_33455268 | 3.57 |
ENST00000522982.1
|
DUSP26
|
dual specificity phosphatase 26 (putative) |
| chr20_+_10199468 | 3.56 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
| chr4_+_76995855 | 3.55 |
ENST00000355810.4
ENST00000349321.3 |
ART3
|
ADP-ribosyltransferase 3 |
| chr10_-_69597810 | 3.54 |
ENST00000483798.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr5_+_140602904 | 3.53 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
| chr1_-_161193349 | 3.53 |
ENST00000469730.2
ENST00000463273.1 ENST00000464492.1 ENST00000367990.3 ENST00000470459.2 ENST00000468465.1 ENST00000463812.1 |
APOA2
|
apolipoprotein A-II |
| chr9_+_71986182 | 3.53 |
ENST00000303068.7
|
FAM189A2
|
family with sequence similarity 189, member A2 |
| chr3_+_113616317 | 3.51 |
ENST00000440446.2
ENST00000488680.1 |
GRAMD1C
|
GRAM domain containing 1C |
| chr12_-_24097236 | 3.50 |
ENST00000538083.1
|
SOX5
|
SRY (sex determining region Y)-box 5 |
| chr6_+_74405501 | 3.49 |
ENST00000437994.2
ENST00000422508.2 |
CD109
|
CD109 molecule |
| chr7_+_1094921 | 3.47 |
ENST00000397095.1
|
GPR146
|
G protein-coupled receptor 146 |
| chr7_+_136553370 | 3.46 |
ENST00000445907.2
|
CHRM2
|
cholinergic receptor, muscarinic 2 |
| chr10_-_118032697 | 3.45 |
ENST00000439649.3
|
GFRA1
|
GDNF family receptor alpha 1 |
| chr1_+_100111479 | 3.44 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
| chr1_+_196743943 | 3.44 |
ENST00000471440.2
ENST00000391985.3 |
CFHR3
|
complement factor H-related 3 |
| chr2_+_189157536 | 3.44 |
ENST00000409580.1
ENST00000409637.3 |
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
| chr16_-_86542455 | 3.43 |
ENST00000595886.1
ENST00000597578.1 ENST00000593604.1 |
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
| chr10_+_24738355 | 3.43 |
ENST00000307544.6
|
KIAA1217
|
KIAA1217 |
| chr6_+_53976235 | 3.43 |
ENST00000502396.1
ENST00000358276.5 |
MLIP
|
muscular LMNA-interacting protein |
| chr6_-_112575912 | 3.42 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
| chr2_+_189157498 | 3.42 |
ENST00000359135.3
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
| chr11_-_35287243 | 3.41 |
ENST00000464522.2
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
| chr3_-_178865747 | 3.41 |
ENST00000435560.1
|
RP11-360P21.2
|
RP11-360P21.2 |
| chr12_-_91576561 | 3.40 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
| chr1_+_209878182 | 3.39 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr14_-_25479811 | 3.39 |
ENST00000550887.1
|
STXBP6
|
syntaxin binding protein 6 (amisyn) |
| chr10_+_31610064 | 3.38 |
ENST00000446923.2
ENST00000559476.1 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
| chr4_+_187148556 | 3.37 |
ENST00000264690.6
ENST00000446598.2 ENST00000414291.1 ENST00000513864.1 |
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1 |
| chr6_+_101847105 | 3.35 |
ENST00000369137.3
ENST00000318991.6 |
GRIK2
|
glutamate receptor, ionotropic, kainate 2 |
| chr1_-_217250231 | 3.33 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
| chr3_+_147657764 | 3.33 |
ENST00000467198.1
ENST00000485006.1 |
RP11-71N10.1
|
RP11-71N10.1 |
| chr4_+_156824840 | 3.32 |
ENST00000536354.2
|
TDO2
|
tryptophan 2,3-dioxygenase |
| chr3_+_158991025 | 3.32 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chr12_+_100867733 | 3.31 |
ENST00000546380.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr1_+_61542922 | 3.28 |
ENST00000407417.3
|
NFIA
|
nuclear factor I/A |
| chr17_-_46035187 | 3.27 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
| chr10_+_115312766 | 3.27 |
ENST00000351270.3
|
HABP2
|
hyaluronan binding protein 2 |
| chr12_-_15374343 | 3.26 |
ENST00000256953.2
ENST00000546331.1 |
RERG
|
RAS-like, estrogen-regulated, growth inhibitor |
| chr10_-_93392811 | 3.26 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
| chr5_-_115872124 | 3.25 |
ENST00000515009.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
| chr12_-_15038779 | 3.25 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
| chr14_-_38064198 | 3.23 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
| chr20_+_10199566 | 3.23 |
ENST00000430336.1
|
SNAP25
|
synaptosomal-associated protein, 25kDa |
| chr12_-_71031220 | 3.21 |
ENST00000334414.6
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
| chr1_-_246729544 | 3.20 |
ENST00000544618.1
ENST00000366514.4 |
TFB2M
|
transcription factor B2, mitochondrial |
| chr12_+_101988627 | 3.19 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr2_+_189839046 | 3.18 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of FOXK1_FOXP2_FOXB1_FOXP3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 12.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 3.2 | 9.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 3.0 | 12.1 | GO:1903314 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 2.8 | 13.8 | GO:0030070 | insulin processing(GO:0030070) |
| 2.4 | 7.3 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
| 2.3 | 6.8 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 2.2 | 8.9 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 2.2 | 17.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 2.2 | 8.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 2.1 | 6.2 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 2.0 | 9.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 1.9 | 7.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.7 | 13.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 1.7 | 11.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 1.7 | 6.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 1.7 | 11.8 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 1.6 | 6.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 1.5 | 6.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 1.5 | 20.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 1.5 | 7.3 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 1.3 | 17.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 1.3 | 8.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 1.3 | 18.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.3 | 10.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 1.3 | 7.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.3 | 8.9 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 1.2 | 13.5 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 1.2 | 3.6 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 1.2 | 9.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 1.2 | 3.5 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 1.1 | 4.4 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.1 | 8.7 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 1.1 | 3.2 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.1 | 19.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.1 | 3.2 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.1 | 6.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.1 | 4.2 | GO:1905069 | allantois development(GO:1905069) |
| 1.1 | 1.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 1.0 | 5.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.0 | 6.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 1.0 | 3.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.0 | 3.0 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 1.0 | 8.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 1.0 | 1.0 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 1.0 | 3.0 | GO:0061075 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 1.0 | 6.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 1.0 | 6.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.0 | 5.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 1.0 | 3.8 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
| 0.9 | 1.9 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.9 | 8.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.9 | 3.7 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.9 | 5.5 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.9 | 2.7 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.9 | 3.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.9 | 5.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.9 | 3.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.9 | 3.5 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.9 | 4.3 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.9 | 12.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.8 | 5.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.8 | 1.7 | GO:0061053 | somite development(GO:0061053) |
| 0.8 | 4.1 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.8 | 4.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.8 | 3.3 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.8 | 3.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.8 | 3.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.8 | 19.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.8 | 11.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.8 | 2.3 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.8 | 3.1 | GO:0060838 | radial pattern formation(GO:0009956) lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.8 | 6.9 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.8 | 1.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.8 | 3.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.7 | 3.0 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.7 | 2.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.7 | 5.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.7 | 2.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.7 | 2.9 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.7 | 7.2 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.7 | 2.2 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.7 | 2.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.7 | 3.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.7 | 5.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.7 | 2.1 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.7 | 4.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.7 | 2.0 | GO:1904640 | response to methionine(GO:1904640) |
| 0.7 | 1.3 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.7 | 2.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.6 | 3.9 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.6 | 11.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.6 | 9.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.6 | 12.6 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.6 | 8.1 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.6 | 3.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.6 | 2.4 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.6 | 25.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.6 | 4.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.6 | 3.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.6 | 2.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.6 | 12.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.6 | 1.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.6 | 3.4 | GO:0030421 | defecation(GO:0030421) |
| 0.6 | 4.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 | 3.4 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.6 | 9.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.6 | 3.4 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.6 | 14.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.6 | 1.1 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.6 | 5.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.5 | 6.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.5 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 | 3.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.5 | 3.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.5 | 1.6 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.5 | 3.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.5 | 2.6 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.5 | 3.1 | GO:0001757 | somite specification(GO:0001757) |
| 0.5 | 2.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.5 | 7.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.5 | 10.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.5 | 3.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.5 | 44.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.5 | 2.0 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.5 | 2.5 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.5 | 6.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.5 | 2.5 | GO:0071453 | cellular response to oxygen levels(GO:0071453) |
| 0.5 | 6.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.5 | 3.0 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.5 | 1.5 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.5 | 8.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.5 | 1.5 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.5 | 11.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.5 | 8.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.5 | 2.8 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.5 | 7.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.5 | 3.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
| 0.5 | 4.1 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.5 | 1.4 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.4 | 4.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.4 | 1.8 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.4 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.4 | 1.3 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.4 | 1.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.4 | 3.0 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.4 | 6.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.4 | 5.6 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.4 | 4.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.4 | 2.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.4 | 1.3 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 20.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.4 | 2.5 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.4 | 1.7 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.4 | 2.5 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 3.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 1.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.4 | 4.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.4 | 4.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.4 | 7.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.4 | 1.2 | GO:0061055 | myotome development(GO:0061055) |
| 0.4 | 1.6 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.4 | 3.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
| 0.4 | 1.6 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.4 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
| 0.4 | 4.2 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.4 | 5.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.4 | 1.9 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.4 | 1.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.4 | 1.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.4 | 1.1 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 0.4 | 3.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.4 | 2.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.4 | 2.2 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.4 | 2.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.4 | 1.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
| 0.4 | 4.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.4 | 5.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.4 | 0.7 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.4 | 3.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.4 | 1.1 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.3 | 10.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 | 5.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.3 | 4.7 | GO:0072189 | ureter development(GO:0072189) |
| 0.3 | 2.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 2.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 0.3 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.3 | 0.7 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.3 | 3.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.3 | 2.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 | 1.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.3 | 6.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.3 | 3.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.3 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 | 2.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.3 | 1.8 | GO:0046530 | photoreceptor cell differentiation(GO:0046530) |
| 0.3 | 1.2 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
| 0.3 | 0.9 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.3 | 1.5 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.3 | 1.2 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 0.3 | 4.6 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.3 | 1.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.3 | 2.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
| 0.3 | 1.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.3 | 11.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.3 | 0.8 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
| 0.3 | 2.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 | 2.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 | 2.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.3 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.3 | 1.4 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.3 | 1.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 | 1.6 | GO:0051216 | cartilage development(GO:0051216) |
| 0.3 | 3.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 5.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.8 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.3 | 1.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.3 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 | 2.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 1.0 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.3 | 5.1 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.3 | 0.5 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.3 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.3 | 8.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.2 | 3.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.2 | 1.2 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.2 | 5.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 1.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.2 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.2 | 1.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.2 | 1.7 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.2 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 1.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 3.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 2.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 | 8.0 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.2 | 2.1 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 0.2 | 2.8 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.2 | 1.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 0.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.2 | 1.6 | GO:0070997 | neuron death(GO:0070997) |
| 0.2 | 7.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 | 1.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) kynurenine metabolic process(GO:0070189) |
| 0.2 | 0.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.2 | 2.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 | 1.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.2 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 0.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.2 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.7 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.2 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 | 3.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.2 | 1.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.2 | 4.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 4.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.2 | 0.6 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.2 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.2 | 1.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 | 1.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.2 | 0.6 | GO:1903216 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.2 | 4.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.2 | 1.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.2 | 1.2 | GO:0036314 | response to sterol(GO:0036314) cellular response to sterol(GO:0036315) |
| 0.2 | 1.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 | 2.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 | 2.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 1.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.2 | 0.6 | GO:1903121 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 | 0.9 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 0.9 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 0.2 | 1.1 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.2 | 3.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 2.4 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 1.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 1.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 2.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 0.9 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
| 0.2 | 0.7 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.2 | 1.8 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 | 2.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.2 | 4.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 2.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 2.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 1.8 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.2 | 1.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 2.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.2 | 0.3 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.2 | 0.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.2 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.2 | 1.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.2 | 0.8 | GO:2000096 | regulation of non-canonical Wnt signaling pathway(GO:2000050) positive regulation of non-canonical Wnt signaling pathway(GO:2000052) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 | 1.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.2 | 1.4 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.2 | 1.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 2.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.2 | 6.5 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.2 | 1.8 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 4.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.2 | 6.2 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 2.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 | 0.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
| 0.2 | 4.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 | 3.9 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.2 | 8.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 | 1.6 | GO:0035864 | response to potassium ion(GO:0035864) |
| 0.2 | 3.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 | 12.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.2 | 0.5 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.2 | 7.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.2 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 5.4 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.2 | 4.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.2 | 3.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.2 | 0.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 3.3 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 25.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.2 | 0.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 0.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 | 2.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.2 | 0.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.1 | 0.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 2.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.1 | 1.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.4 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
| 0.1 | 3.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 4.5 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.1 | 0.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.1 | 0.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 3.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 0.8 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 2.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 1.9 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 1.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 0.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.1 | 0.7 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.1 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 1.1 | GO:1902998 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 | 0.4 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.1 | 1.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 3.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 5.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 3.9 | GO:0001501 | skeletal system development(GO:0001501) |
| 0.1 | 12.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 1.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.7 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.1 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 | 0.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
| 0.1 | 2.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.6 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 | 1.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 0.5 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 | 2.5 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.1 | 0.6 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 1.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 1.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 1.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 2.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 3.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 0.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 4.2 | GO:0070741 | response to interleukin-6(GO:0070741) |
| 0.1 | 3.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 6.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 3.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.8 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 | 0.6 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 3.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 1.4 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 4.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 | 1.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 0.6 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.2 | GO:0006664 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.1 | 0.6 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
| 0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 1.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.1 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 0.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 5.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.1 | 0.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 | 0.3 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.1 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 | 0.3 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.1 | 1.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 4.0 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 1.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.1 | 3.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 | 1.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.1 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.4 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.1 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 2.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 1.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 0.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 | 0.3 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 2.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 2.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 2.2 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 0.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.9 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.4 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 1.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.7 | GO:0009597 | detection of virus(GO:0009597) |
| 0.1 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 2.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 1.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.1 | 0.2 | GO:0060455 | response to anoxia(GO:0034059) negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 | 0.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 | 0.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 13.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.3 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.1 | 0.3 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 | 0.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.1 | 2.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.0 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.1 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
| 0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 3.7 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 | 3.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.3 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 0.2 | GO:0072114 | pronephros morphogenesis(GO:0072114) |
| 0.1 | 1.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.1 | 50.9 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.1 | 0.2 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 | 2.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 2.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.2 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 1.4 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.1 | 1.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.7 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 1.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 0.4 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.1 | 0.2 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.6 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 | 1.0 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 | 0.4 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 1.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 1.9 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.1 | 1.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.3 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 1.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 0.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
| 0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.1 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.1 | 1.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 0.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 4.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 3.1 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 3.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.1 | 1.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.1 | 0.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 | 7.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.1 | 1.1 | GO:0007420 | brain development(GO:0007420) |
| 0.1 | 1.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 0.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.1 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.1 | 1.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.7 | GO:0048512 | circadian behavior(GO:0048512) |
| 0.1 | 2.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 | 0.2 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.1 | 1.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.1 | 0.4 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 2.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 1.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 | 1.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.1 | 0.1 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 1.2 | GO:0032528 | microvillus organization(GO:0032528) |
| 0.1 | 0.6 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.3 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 | 0.4 |